BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38619575)

  • 1. Safety and feasibility of early discharge after transcatheter aortic valve implantation with ACURATE Neo-the POLESTAR trial.
    Ooms JF; Cornelis K; Wijeysundera HC; Vandeloo B; Van Der Heyden J; Kovac J; Wood D; Chan A; Wykyrzykowska J; Rosseel L; Cunnington M; van der Kley F; Rensing B; Voskuil M; Hildick-Smith D; Van Mieghem NM
    Clin Res Cardiol; 2024 Apr; ():. PubMed ID: 38619575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and Design of the Project to Look for Early Discharge in Patients Undergoing TAVR With ACURATE (POLESTAR Trial).
    Ooms JF; Cornelis K; Stella PR; Rensing BJ; Van Der Heyden J; Chan AW; Wykrzykowska JJ; Rosseel L; Vandeloo B; Lenzen MJ; Cunnington MS; Hildick-Smith D; Wijeysundera HC; Van Mieghem NM
    Cardiovasc Revasc Med; 2022 Nov; 44():71-77. PubMed ID: 35739011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
    Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial.
    Tamburino C; Bleiziffer S; Thiele H; Scholtz S; Hildick-Smith D; Cunnington M; Wolf A; Barbanti M; Tchetchè D; Garot P; Pagnotta P; Gilard M; Bedogni F; Van Belle E; Vasa-Nicotera M; Chieffo A; Deutsch O; Kempfert J; Søndergaard L; Butter C; Trillo-Nouche R; Lotfi S; Möllmann H; Joner M; Abdel-Wahab M; Bogaerts K; Hengstenberg C; Capodanno D
    Circulation; 2020 Dec; 142(25):2431-2442. PubMed ID: 33054367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of CT-derived simulations of transcatheter-aortic-valve-implantation in challenging anatomies the PRECISE-TAVI trial.
    Hokken TW; Wienemann H; Dargan J; Ginkel DV; Dowling C; Unbehaun A; Bosmans J; Bader-Wolfe A; Gooley R; Swaans M; Brecker SJ; Adam M; Van Mieghem NM
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):1140-1148. PubMed ID: 37668110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve implantation with different self-expanding devices-a propensity score-matched multicenter comparison.
    Wienemann H; Hof A; Ludwig S; Veulemans V; Sedaghat A; Iliadis C; Meertens M; Macherey S; Hohmann C; Kuhn E; Al-Kassou B; Wilde N; Schofer N; Bleiziffer S; Maier O; Kelm M; Baldus S; Rudolph TK; Adam M; Mauri V
    Hellenic J Cardiol; 2023; 70():1-9. PubMed ID: 36538975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAVI with the ACURATE neo transcatheter heart valve in special populations: A systematic review.
    Koliastasis L; Doundoulakis I; Kokkinidis DG; Milkas A; Drakopoulou M; Benetos G; Latsios G; Synetos A; Aggeli K; Tousoulis D; Tsioufis K; Toutouzas K
    Hellenic J Cardiol; 2022; 66():67-71. PubMed ID: 35508295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First North American experience with the transfemoral ACURATE-neo
    Bagur R; Teefy PJ; Kiaii B; Diamantouros P; Chu MWA
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):130-138. PubMed ID: 27677241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
    Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
    JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes.
    Möllmann H; Holzhey DM; Hilker M; Toggweiler S; Schäfer U; Treede H; Joner M; Søndergaard L; Christen T; Allocco DJ; Kim WK
    Clin Res Cardiol; 2021 Dec; 110(12):1912-1920. PubMed ID: 34148125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry).
    Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Schofer J; Hildick-Smith D; Pilgrim T; Abizaid A; Zweiker D; Testa L; Taramasso M; Wolf A; Webb JG; Sedaghat A; Van der Heyden JAS; Ziviello F; MacCarthy P; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Eitan A; Alsanjari O; Asami M; Windecker S; Siqueira D; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Jensen CJ; Naber CK; Alenezi A; Wood DA; Sinning JM; Brouwer J; Tzalamouras V; Van Mieghem NM; Colombo A; Latib A
    Am J Cardiol; 2020 May; 125(9):1369-1377. PubMed ID: 32098656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.
    Barbanti M; Baan J; Spence MS; Iacovelli F; Martinelli GL; Saia F; Bortone AS; van der Kley F; Muir DF; Densem CG; Vis M; van Mourik MS; Seilerova L; Lüske CM; Bramlage P; Tamburino C
    BMC Cardiovasc Disord; 2017 Oct; 17(1):259. PubMed ID: 29017461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year clinical outcome with a novel self-expanding transcatheter heart valve.
    Pellegrini C; Rheude T; Trenkwalder T; Mayr NP; Michel J; Kastrati A; Schunkert H; Kasel AM; Joner M; Hengstenberg C; Husser O
    Catheter Cardiovasc Interv; 2019 Nov; 94(6):783-792. PubMed ID: 30801906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter Aortic Valve Implantation with ACURATE
    Kim WK; Thiele H; Linke A; Kuntze T; Fichtlscherer S; Webb J; Chu MWA; Adam M; Schymik G; Geisler T; Kharbanda R; Christen T; Allocco D
    J Interv Cardiol; 2022; 2022():9138403. PubMed ID: 35832535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation:
    Khokhar AA; Ponticelli F; Zlahoda-Huzior A; Chandra K; Ruggiero R; Toselli M; Gallo F; Cereda A; Sticchi A; Laricchia A; Regazzoli D; Mangieri A; Reimers B; Biscaglia S; Tumscitz C; Campo G; Mikhail GW; Kim WK; Colombo A; Dudek D; Giannini F
    Front Cardiovasc Med; 2022; 9():902564. PubMed ID: 36187005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve.
    Schneeberger Y; Seiffert M; Schaefer A; Bhadra OD; Schofer N; Pecha S; Westermann D; Blankenberg S; Reichenspurner H; Conradi L
    Front Cardiovasc Med; 2021; 8():743579. PubMed ID: 35146003
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the outcome of elective vs non-elective patients undergoing transcatheter aortic valve implantation different? Results of a single-centre, observational assessment of outcomes at a large university clinic.
    Wundram S; Seoudy H; Dümmler JC; Ritter L; Frank J; Puehler T; Lutter G; Lutz M; Saad M; Bramlage P; Sathananthan J; Wood DA; Lauck SB; Frey N; Frank D
    BMC Cardiovasc Disord; 2023 Jun; 23(1):295. PubMed ID: 37301870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Self-Expanding Transcatheter Aortic Valve Device for Transfemoral Implantation- Early Results of the First-in-Asia Implantation of the ACURATE Neo/TF(TM) System.
    Maeda K; Kuratani T; Torikai K; Mizote I; Ichibori Y; Onishi T; Nakatani S; Sakata Y; Toda K; Sawa Y
    Circ J; 2015; 79(5):1037-43. PubMed ID: 25740501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis.
    Yousef A; Simard T; Webb J; Rodés-Cabau J; Costopoulos C; Kochman J; Hernández-Garcia JM; Chiam PT; Welsh RC; Wijeysundera HC; García E; Ribeiro HB; Latib A; Huczek Z; Shanks M; Testa L; Farkouh ME; Dvir D; Velianou JL; Lam BK; Pourdjabbar A; Glover C; Hibbert B; Labinaz M
    Int J Cardiol; 2015; 189():282-8. PubMed ID: 25910593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.